Review examines metabolic reprogramming and DNA repair mechanisms in prostate cancer, suggesting treatment vulnerabilities.
Dysregulation of metabolism and the DNA damage response are two hallmarks of cancer. With respect to the former, although most cancer types exhibit increased glycolysis (the Warburg effect), this is not the case for prostate cancer. Accordingly, we review the unique metabolic features of prostate cancer, including androgen receptor signaling, glucose metabolism, treatment vulnerabilities, metformin, and combination therapies. With respect to the latter, we review genomic instability in cancer, DNA repair subtypes, the role of Mre11 in DNA double-strand break repair, and the potential regulation of Mre11 by Plk1-mediated phosphorylation.
No takes yet. Share an insight, caveat, or question.
Simpson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: